CRW Craneware Plc

TIDMCRW

RNS Number : 3412E

Craneware plc

05 April 2011

Craneware plc

("Craneware" or the "Company")

Director Shareholding & Issue of Equity

05 April 2011 - Craneware plc (AIM: CRW.L; OTC: CRWRY), the market leader in automated revenue integrity solutions for the US healthcare market, announces that it has received notice from Keith Neilson, CEO of the Company to exercise options in respect of 20,000 new ordinary shares of 1 pence each in the Company ('Ordinary Shares'). After the exercise of these options Mr. Neilson will have a total holding in the Company of 3,448,779 Ordinary Shares which represents 12.89% of the total issued share capital.

These options were granted on 13 September 2007 at the time of the Company's IPO under the Company's Approved Share Option Plan 2007 at an exercise price of 1p per share.

The Company has also received notice from other employees to exercise options in respect of a further 190,000 Ordinary Shares, also at an exercise price of 1p per share.

Following the exercise of all of these options and including the 16,095 Ordinary Shares expected to be admitted on 7 April 2011, the total issued share capital of the Company with voting rights will be 26,762,134 Ordinary Shares. The Company does not hold any Ordinary Shares in Treasury.

From 7 April 2011 the above figure of 26,762,134 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

For further information, please contact:

 
 Craneware plc     Peel Hunt          Threadneedle Communications 
 +44 (0)131 550    +44 (0)20 7418 
  3100              8900              +44 (0)20 7653 9850 
 Keith Neilson,    Dan Webster        Caroline Evans-Jones 
  CEO 
 Craig Preston,    Richard Kauffer    Fiona Conroy 
  CFO 
 

About Craneware

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance and mitigate risk for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. These optimise reimbursement, increase operational efficiency and minimise compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com and stoptheleakage.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSDKPDKNBKDCQK

Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024